A Chemical Screen Identifies Anisomycin As an Anoikis Sensitizer That Functions by Decreasing Flip Protein Synthesis.
From: Ontario Cancer Institute, Princess Margaret Hospital, Mt Sinai Hospital, Toronto, Ontario, Canada.
Cancer research
- Publish Date: Sep 2007
- ISSN: 0008-5472
- Volume: 67
- Issue: 17
- Pages: 8307-15
- Medium: Print
- Language: English
- Citation (JAMA): Mawji Imtiaz A, Simpson Craig D, Gronda Marcela, et al. A Chemical Screen Identifies Anisomycin As an Anoikis Sensitizer That Functions by Decreasing Flip Protein Synthesis.. Cancer Res. Sep 2007;67:8307-15
Abstract
Malignant epithelial cells with metastatic potential resist apoptosis that normally occurs upon loss of anchorage from the extracellular matrix, a process termed “anoikis.” Resistance to anoikis enables malignant cells to survive in an anchorage-independent manner, which leads to the formation of distant metastases. To understand the regulation of anoikis, we designed, automated, and conducted a high-throughput chemical screen for anoikis sensitizers. PPC-1 anoikis-resistant prostate cancer cells were seeded in hydrogel-coated ultralow binding plates for suspension conditions and standard tissue culture plates to promote adhesion. After seeding, cells were treated with aliquots from a library of previously characterized small molecules, and viability was assessed using the 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt, assay. From this chemical screen, we identified anisomycin that induced apoptosis in suspension conditions, but was not toxic to these cells grown under adherent conditions. Anisomycin sensitized cells to anoikis by decreasing levels of the caspase-8 inhibitor FLIP and subsequently activating the death receptor pathway of caspase activation. Although anisomycin activated c-Jun-NH(2)-kinase and p38, these kinases were not functionally important for the effect of anisomycin on anoikis and FLIP. Rather, anisomycin decreased FLIP and sensitized cells to anoikis by inhibiting its protein synthesis. Finally, we showed that anisomycin decreased distal tumor formation in a mouse model of prostate cancer metastases. Thus, a novel chemical screen identified anisomycin as an anoikis sensitizer that acts by decreasing FLIP protein synthesis. Our results suggest that FLIP is a suppressor of anoikis and inhibiting FLIP protein synthesis may be a useful antimetastatic strategy.
Mesh Headings (Keywords): Animals, Anisomycin, Anoikis, CASP8 and FADD-Like Apoptosis Regulating Protein, Caspases, Cell Survival, Drug Screening Assays, Antitumor, Humans, Male, Mice, Models, Biological, Neoplasm Circulating Cells, Neoplasm Metastasis, Prostatic Neoplasms, Protein Biosynthesis, Receptors, Death Domain, Tumor Cells, Cultured
Check for Full Text / PubMed Unique Identifier (PMID): 17804746
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.